| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 667348 | 70763 | EPIRUBICINA TEVA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG | EPIRUBICINA TEVA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial de 25 ml | 2 mg/ml inyectable 25 ml | 45 | 1 | 34 | 1 vial de 25 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70763/70763_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70763/70763_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2010-04-05 | 1 | 1 | 1 | 2010-04-05 | 2010-04-05 | 1 | 2011-09-26 | View Edit Delete | ||||||||||||
| 667350 | 70763 | EPIRUBICINA TEVA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG | EPIRUBICINA TEVA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial de 100 ml | 2 mg/ml inyectable 100 ml | 45 | 1 | 34 | 1 vial de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70763/70763_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70763/70763_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2010-04-05 | 1 | 1 | 1 | 2010-04-05 | 2010-04-05 | 1 | 2011-09-26 | View Edit Delete | ||||||||||||
| 667541 | 70642 | ZOMACTON 10 mg/ ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ZOMACTON 10 mg/ ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 10 mg | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70642/70642_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70642/70642_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31840 | FERRING S.A.U. | 2010-03-23 | 1 | 1 | 1 | 2010-03-23 | 2010-03-23 | 1 | 2011-06-28 | View Edit Delete | ||||||||||||
| 665883 | 10645002 | BRINAVESS 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSION | BRINAVESS 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 25 ml | 20 mg/ml inyectable 25 ml | 45 | 1 | 34 | 1 vial de 25 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10645002/10645002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10645002/10645002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41367 | ADVANZ PHARMA SPAIN S.L.U. | 2010-10-19 | 1 | 1 | 1 | 2010-10-19 | 2010-10-19 | 1 | 2012-02-27 | View Edit Delete | ||||||||||||
| 668822 | 61671 | VARILRIX POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA | VARILRIX POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA, 1 vial + 1 jeringa precargada + 2 agujas | N/A (vacuna) | 45 | 1 | 34 | 1 vial + 1 jeringa precargada + 2 agujas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61671/61671_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61671/61671_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 666610 | 62635 | CEFTRIAXONA NORMON 1000 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSION EFG | CEFTRIAXONA NORMON 1000 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSION EFG, 1 vial + 1 ampolla de disolvente | 1.000 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62635/62635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62635/62635_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-06-01 | 1 | 1 | 1 | 1999-06-01 | 1999-06-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 668830 | 61670 | BUDESONIDA NASAL ALDO-UNIÓN 100 microgramos/dosis SUSPENSION PARA PULVERIZACION NASAL | BUDESONIDA NASAL ALDO-UNIÓN 100 microgramos/dosis SUSPENSION PARA PULVERIZACION NASAL , 1 envase pulverizador de 200 dosis | 100 microgramos/dosis | 45 | 200 | 31 | 1 envase pulverizador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61670/61670_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61670/61670_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 1998-02-01 | 1 | 1 | 1 | 1998-02-01 | 1998-02-01 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 667711 | 70704 | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 5 ml | 6 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70704/70704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70704/70704_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2010-10-15 | 1 | 1 | 1 | 2010-10-15 | 2010-10-15 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 667712 | 70704 | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 16,7 ml | 6 mg/ml inyectable 16,7 ml | 45 | 1 | 34 | 1 vial de 16,7 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70704/70704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70704/70704_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2010-10-15 | 1 | 1 | 1 | 2010-10-15 | 2010-10-15 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 667713 | 70704 | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 50 ml | 6 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70704/70704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70704/70704_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2010-10-15 | 1 | 1 | 1 | 2010-10-15 | 2010-10-15 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 669790 | 71346 | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 10 ml | 5 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71346/71346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71346/71346_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-04-06 | 1 | 1 | 1 | 2011-04-06 | 2011-04-06 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 669791 | 71346 | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 20 ml | 5 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71346/71346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71346/71346_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-04-06 | 1 | 1 | 1 | 2011-04-06 | 2011-04-06 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 670615 | 72377 | BOTOX 200 UNIDADES ALLERGAN, POLVO PARA SOLUCIÓN INYECTABLE | BOTOX 200 UNIDADES ALLERGAN, POLVO PARA SOLUCIÓN INYECTABLE , 1 vial | 200 U | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72377/72377_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72377/72377_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16052 | ABBVIE SPAIN, S.L.U. | 2011-04-08 | 1 | 1 | 1 | 2011-04-08 | 2011-04-08 | 1 | 2018-02-14 | View Edit Delete | ||||||||||||
| 668889 | 61665 | DECAPEPTYL TRIMESTRAL 11,25 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA INYECTABLE | DECAPEPTYL TRIMESTRAL 11,25 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA INYECTABLE, 1 vial + 1 ampolla de disolvente | 11,25 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61665/61665_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61665/61665_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68629 | IPSEN PHARMA S.A.U. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 667659 | 61732 | ADENOSCAN 30 mg/10 ml SOLUCION PARA PERFUSION | ADENOSCAN 30 mg/10 ml SOLUCION PARA PERFUSION , 6 viales de 10 ml | 30 mg | 45 | 6 | 34 | 6 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61732/61732_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61732/61732_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40842 | SANOFI AVENTIS S.A. | 1998-04-01 | 1 | 1 | 1 | 1998-04-01 | 1998-04-01 | 1 | 2011-06-09 | View Edit Delete | ||||||||||||
| 665953 | 05318002 | REVATIO 0,8 MG/ML SOLUCION INYECTABLE | REVATIO 0,8 MG/ML SOLUCION INYECTABLE, 1 vial de 12,5 ml | 0,8 mg/ml inyectable 12,5 ml | 45 | 1 | 34 | 1 vial de 12,5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05318002/05318002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05318002/05318002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 33758 | VIATRIS PHARMACEUTICALS S.L. | 2011-03-10 | 1 | 1 | 1 | 2011-03-10 | 2011-03-10 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 665881 | 10646002 | VPRIV 400 UNIDADES POLVO PARA SOLUCION PARA PERFUSION | VPRIV 400 UNIDADES POLVO PARA SOLUCION PARA PERFUSION, 1 vial | 400 UI | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10646002/10646002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10646002/10646002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 42050 | TAKEDA FARMACEUTICA ESPANA S.A. | 2010-10-28 | 1 | 1 | 1 | 2010-10-28 | 2010-10-28 | 1 | 2011-05-19 | View Edit Delete | ||||||||||||
| 665854 | 10622001 | TEPADINA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | TEPADINA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial | 15 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10622001/10622001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10622001/10622001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34778 | LAPHYSAN S.A.U. | 2010-10-29 | 1 | 1 | 1 | 2010-10-29 | 2010-10-29 | 0 | 2011-09-23 | View Edit Delete | ||||||||||||
| 665855 | 10622002 | TEPADINA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | TEPADINA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10622002/10622002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10622002/10622002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34778 | LAPHYSAN S.A.U. | 2010-10-29 | 1 | 1 | 1 | 2010-10-29 | 2010-10-29 | 0 | 2011-09-23 | View Edit Delete | ||||||||||||
| 665878 | 07437003 | IVEMEND 150 MG POLVO PARA SOLUCION PARA PERFUSION | IVEMEND 150 MG POLVO PARA SOLUCION PARA PERFUSION , 1 vial | 150 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07437003/07437003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07437003/07437003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | MERCK SHARP & DOHME DE ESPANA S.A. | 2010-10-04 | 1 | 1 | 1 | 2010-10-04 | 2010-10-04 | 1 | 2011-06-09 | View Edit Delete |
Page 246 of 1035, showing 20 records out of 20689 total, starting on record 4901, ending on 4920